论文部分内容阅读
目的:对预混人胰岛素注射液甘舒霖R治疗2型糖尿病的临床价值进行分析和探讨。方法:选择2012年9月-2014年9月在我院就诊的40例2型糖尿病患者为研究对象,随机分组为观察组与对照组各20例,观察组给予甘舒霖R治疗,对照组给予优泌林R治疗,为期3个月。评价指标为糖化血红蛋白(HbA1c)、空腹血糖(FPG)、餐后2h血糖(2hPG)水平,比较2组患者各项检测结果。结果:观察组与对照组治疗前各项检测指标比较无显著性差异(P>0.05);治疗3个月后,2组患者HbA1c、FPG和2hPG水平均明显降低,组内比较差异显著,P<0.05,但2组间各项指标比较差异不显著,P>0.05。结论:预混人胰岛素注射液甘舒霖R可显著降低2型糖尿病糖化血红蛋白(HbA1c)、空腹血糖(FPG)、餐后2h血糖(2hPG)水平,且其治疗效果与优泌林R相当,在治疗2型糖尿病上有很高的临床价值。
Objective: To analyze and discuss the clinical value of premixed insulin injection Gan Shu Lin R in the treatment of type 2 diabetes mellitus. Methods: Forty patients with type 2 diabetes mellitus who were treated in our hospital from September 2012 to September 2014 were randomly divided into observation group (n = 20) and control group (n = 20). The observation group was treated with Ganshuolin R and the control group Rulin R treatment for a period of 3 months. The evaluation indexes included HbA1c, fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG), and the results of the two groups were compared. Results: There was no significant difference between the observation group and the control group before treatment (P> 0.05). After 3 months of treatment, the levels of HbA1c, FPG and 2hPG in both groups were significantly decreased <0.05, but there was no significant difference between the two groups (P> 0.05). CONCLUSION: Pre-mixed insulin Ganshulin R can significantly reduce the level of HbA1c, fasting blood glucose (FPG) and 2h postprandial blood glucose (2hPG) in type 2 diabetic patients. Type 2 diabetes has a high clinical value.